Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Afamin (AFM) is a secreted, monomeric glycoprotein that belongs to the albumin family of serum transport proteins, which also includes serum albumin, alpha-fetoprotein, and vitamin D binding protein[1][3]. It is primarily synthesized in the liver and circulates in blood at low microgram-per-milliliter concentrations[1][3]. Afamin’s biological functions include binding and transport of vitamin E (alpha-tocopherol) and acting as a carrier for Wnt proteins, thereby facilitating their solubility and availability for signaling, especially at the blood-brain barrier and in bone biology[1][2]. Recent studies have suggested that afamin may play a role as a chemoattractant for preosteoblasts, coupling bone resorption and formation, and as a unique carrier for several lipidated Wnt ligands distinct from other albumin family proteins[1][2]. Abnormal levels of afamin have been associated with several conditions, including pre-eclampsia, ovarian cancer, and both gestational and type 2 diabetes, suggesting its potential utility as a biomarker in these diseases[1][3]. There are currently no drugs known to act directly on afamin, and it is not considered a therapeutic target such as a receptor, enzyme, or transporter[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Afamin (AFM).